BioLife Sciences Common Stock

BioLife Sciences (BLFE) currently reports a common stock of $5 as of February 2022. That compares with $5.5K in the prior-year period — down 99.9% year over year. Use the charts on this page to explore BioLife Sciences's common stock history and peer comparisons.

BioLife Sciences's common stock decreased from $5.5K to $5 — a 99.9% year-over-year decrease (period ending February 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioLife Sciences reported $5 in common stock as of February 2022. That compares with $5.5K in the prior-year period — down 99.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $5, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioLife Sciences, and consider following BLFE for alerts when major investors trade the stock.